Pectoralis Nerve Block and Quality of Recovery in Mastectomy Patients

January 18, 2023 updated by: Young Song, Gangnam Severance Hospital

The Effect of Pectoralis Nerve Block on Quality of Recovery in Patients Undergoing Breast-conservative Surgery

Effects of pectoralis nerve block on quality of recovery after breast surgery has been debated. We hypothesized there might exist relevant psychosocial factor or variable of pain sensitivity which would influence on the benefit of nerve block.

This study aims to assess effect of pectoralis nerve block on QoR-15 score in subgroups stratified by such factors.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Study population All of patients will undergo partial mastectomy. 140 patients will be enrolled.

Intervention Pectoralis nerve block will be performed in the Block group.

Psychosocial factor screening Pain-detect, HADS, EQ-5D, PHQ-15 (somatic symptom), PCS (pain catastrophizing), BFI (big five inventory), HAM-A&D, Pressure algometry (Pain sensitivity), Quantitative sensory test (pinprick)

Study endpoints Quality of recovery (QoR)-15 Pain visual analogue scale Opioid consumption Breast Cancer Pain Questionnaire (BCPQ)

Study Type

Interventional

Enrollment (Anticipated)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients aged 20 to 80 years who underwent partial mastectomy for breast cancer.

Exclusion Criteria:

  • Patients with a history of previous breast surgery
  • Patients with a history of adverse reactions to local anesthetics
  • Patients with a history of drug addiction
  • Patients with cancer other than breast
  • Patients with chronic pain who require analgesics
  • History of hospitalization for psychiatric disorders
  • Preoperative pulse oximetry (SpO2) < 95 %
  • Left ventricular ejection fraction < 40%
  • Moderate or severe hepatic impairment
  • Body mass index over 35 kg/m2
  • Blood clotting disorders
  • Pregnant/lactating women
  • Inability to understand consent forms and answer research questionnaires due to cognitive impairment
  • Unable to read consent form (eg illiterate, foreigner, etc.)
  • do not perform axillary lymph node dissection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Block group
The group undergoing PECs block
The PECs block is performed immediately after induction of anesthesia, and 0.375% concentration of ropivacaine (carbiropivacaine injection, Fresinius Kavi Korea Co., Ltd.) is used with a 25 G 5 cm (or 8 cm) needle to induce ultrasound-guided pectoralis major (pectoralis major). 10mL (PECs I block) into the fascia between the pectoralis minor muscle) and the pectoralis minor muscle, and 20mL (PECs II block) between the pectoralis minor and serratus anterior muscle.
Placebo Comparator: Control group
The group not receiving PECs block
In this group, the PECs block was not implemented.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QoR-15
Time Frame: Postoperative day 1
To compare the difference in the quality of recovery between groups, the QoR-15 questionnaire is administered on the 1st day after surgery.
Postoperative day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intensity of pain
Time Frame: Postoperative day 0, 1
Intensity of pain will be recorded by using VAS (0-10).
Postoperative day 0, 1

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preoperative psychological factors: HADS
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety and depression symptoms will be assessed by HADS (Hospital Anxiety and Depression Scale) questionnaire.
1-5 days before surgery, 1st OPD visit after surgery
Preoperative psychological factors: EQ-5D
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety and depression symptoms will be assessed by EQ-5D.
1-5 days before surgery, 1st OPD visit after surgery
Preoperative psychological factors and pain sensitivity test: PHQ-15
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety, depression symptoms and pain sensitivity will be assessed by PHQ-15.
1-5 days before surgery, 1st OPD visit after surgery
Preoperative psychological factors and pain sensitivity test: pain catastrophizing scale
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety, depression symptoms and pain sensitivity will be assessed by pain catastrophizing scale.
1-5 days before surgery, 1st OPD visit after surgery
Preoperative psychological factors: big five inventory
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety and depression symptoms will be assessed by big five inventory.
1-5 days before surgery, 1st OPD visit after surgery
Preoperative psychological factors: HAM-A&D
Time Frame: 1-5 days before surgery, 1st OPD visit after surgery
Presence of anxiety and depression symptoms will be assessed by HAM-A&D.
1-5 days before surgery, 1st OPD visit after surgery
Patient State Index
Time Frame: perioperative period
Depth of anesthesia will be recorded by using frontal electroencephalogram (Patient State Index, The PSi is a processed EEG parameter that is related to the effect of anesthetic agents, and takes into consideration, among other factors: (1) changes in power in various EEG frequency bands; (2) changes in symmetry and synchronization between critical brain regions; and (3) the inhibition of regions of the frontal cortex.) during operation
perioperative period
analgesic nociception index
Time Frame: perioperative period
Intensity of pain will be recorded by using analgesic nociception index during operation
perioperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2022

Primary Completion (Anticipated)

February 23, 2024

Study Completion (Anticipated)

March 24, 2025

Study Registration Dates

First Submitted

February 23, 2022

First Submitted That Met QC Criteria

February 23, 2022

First Posted (Actual)

March 4, 2022

Study Record Updates

Last Update Posted (Actual)

January 20, 2023

Last Update Submitted That Met QC Criteria

January 18, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 3-2021-0468

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on PECs block

Subscribe